Latest news
Insider at ProMIS Neurosciences (PMN) buys 2,280 common shares - Stock TitanStock Titan · Fri, 07 Aug 2026 20:00:59 GMTPromis Neurosciences (NASDAQ:PMN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeatMarketBeat · Fri, 07 Aug 2026 06:52:00 GMTProMIS challenges Alzheimer’s treatment playbook - Longevity.TechnologyLongevity.Technology · Tue, 04 Aug 2026 16:41:55 GMTProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026 - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 20:00:00 GMTProMIS schedules 4:30 p.m. webcast for Aug. 13 update - Stock TitanStock Titan · Mon, 03 Aug 2026 20:00:00 GMTProMIS Neurosciences to report Q2 2026 financia... - PluangPluang · Mon, 03 Aug 2026 07:00:00 GMTPromis Neurosciences (NASDAQ:PMN) Upgraded at Chardan Capital - MarketBeatMarketBeat · Wed, 29 Jul 2026 07:00:00 GMTProMIS Neurosciences (PMN) Reports Promising Interim Biomarker D - GuruFocusGuruFocus · Tue, 28 Jul 2026 14:44:24 GMT